Avacta Group (LON:AVCT) Stock Price Down 6.5% – Should You Sell?

Avacta Group Plc (LON:AVCT) shares traded down 6.5% during mid-day trading on Thursday . The stock traded as low as GBX 42.27 ($0.54) and last traded at GBX 43.25 ($0.55). 1,947,396 shares were traded during mid-day trading, a decline of 16% from the average session volume of 2,306,089 shares. The stock had previously closed at GBX 46.25 ($0.59).

Avacta Group Price Performance

The stock has a market capitalization of £154.96 million, a P/E ratio of -480.56 and a beta of 1.12. The company has a debt-to-equity ratio of 63.54, a quick ratio of 4.96 and a current ratio of 1.29. The business has a fifty day simple moving average of GBX 51.40 and a 200-day simple moving average of GBX 57.56.

Avacta Group Company Profile

Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.